Allergan Strikes $200M Deal To Exit NY Opioid Trial
By Cara Salvatore · December 8, 2021, 11:11 AM EST
Allergan has reached a settlement worth up to $200 million to end its participation in a closely watched New York opioid trial brought by state and county governments, according to a Wednesday announcement....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login